Schonfeld Strategic Advisors LLC Vista Gen Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $176 - $346	200 Added 0.11%	175,100 $155,000
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $240,881 - $441,616	-211,300 Reduced 54.71%	174,900 $217,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $60,621 - $100,187	-36,300 Reduced 8.59%	386,200 $753,000
Q3 2021 Nov 16, 2021	SELL	$2.62 - $3.45 $500,682 - $659,295	-191,100 Reduced 31.14%	422,500 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $673,849 - $1.08 Million	343,801 Added 127.43%	613,600 $1.93 Million
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $362,311 - $567,429	191,699 Added 245.45%	269,799 $574,000
Q4 2020 Feb 16, 2021	BUY	$0.65 - $1.94 $50,765 - $151,514	78,100 New	78,100 $152,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.